Investment company PhiloSmith Capital Corp buys Validus Holdings, Black Knight Inc, sells Chubb, Arch Capital Group, First American Financial Corp, Hiscox during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, PhiloSmith Capital Corp. As of 2017-12-31, PhiloSmith Capital Corp owns 30 stocks with a total value of $115 million. These are the details of the buys and sells.
New Purchases: BKI, Added Positions: VR, JRVR, Reduced Positions: PRI, RJF, BRO, AEL, RGA, RLI, Sold Out: CB, ACGL, FAF, HCXLF,
For the details of PhiloSmith Capital Corp’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PhiloSmith+Capital+Corp
These are the top 5 holdings of PhiloSmith Capital CorpPrimerica Inc (PRI) – 106,700 shares, 9.44% of the total portfolio. Shares reduced by 13.04%Reinsurance Group of America Inc (RGA) – 60,550 shares, 8.23% of the total portfolio. Shares reduced by 7.63%Brown & Brown Inc (BRO) – 178,225 shares, 7.99% of the total portfolio. Shares reduced by 7.76%Arthur J. Gallagher & Co (AJG) – 143,725 shares, 7.93% of the total portfolio. Mentor Graphics Corp (MENT) – 47,700 shares, 7.04% of the total portfolio. Shares reduced by 17.33%New Purchase: Black Knight Inc (BKI)
PhiloSmith Capital Corp initiated holdings in Black Knight Inc. The purchase prices were between $42 and $46.85, with an estimated average price of $45.2. The stock is now traded at around $46.70. The impact to the portfolio due to this purchase was 1.3%. The holdings were 33,881 shares as of 2017-12-31.
Top 10 Value Stocks For 2018: Brunswick Corporation(BC)
- [By Stephan Byrd]
ILLEGAL ACTIVITY WARNING: “$1.15 Billion in Sales Expected for Brunswick Co. (BC) This Quarter” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at www.tickerreport.com/banking-finance/3380347/1-15-billion-in-sales-expected-for-brunswick-co-bc-this-quarter.html.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Brunswick (BC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Value Stocks For 2018: New Media Investment Group Inc.(NEWM)
- [By Joseph Griffin]
New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.
Top 10 Value Stocks For 2018: Biotricity (BTCY)
- [By Robert J. Smith]
Biotricity (OTCBB: BTCY) is a comer in the rapidly growing medical device market and is a small cap to take notice of. Driving this lucrative market are; IoT-driven device connectivity, governmental pressure to cut healthcare costs, escalating hospital costs, a need to reduce hospital readmission rates, an aging population, and a high rate of people with chronic disease. The largest factor driving this market is the rapidly growing rate of those afflicted with chronic disease.
- [By James E. Brumley]
Biotricity Inc (OTCMKTS:BTCY), a developer of remote health-monitoring devices, reminded us not so gently today that while it’s waiting on the last of the necessary approvals from the FDA for its hardware, it’s still moving the ball downfield (so to speak). That is to say, it’s already lined up a manufacturer for its so-called Bioflux cardiac monitor for when the last green light is given, and it’s a good one…. Providence Enterprise . That’s the same company that makes some of the equipment and goods within your sight right now.
Biotricity is the name behind two pieces of technology, both of which are nearing the end of their development. One is the aforementioned Bioflux, and the other is called biolife…. the latter for use by individuals outside of a clinical setting. Neither is on the market yet, but both are projected to be on the market this year. In fact, the company demonstrated its IoT-connected bioflux at this year’s Mobile World Congress (MWC) 2017 in Barcelona, Spain a couple of weeks ago. The crowd liked what it saw.
The marketable version of the device isn’t available yet; it’s still going through the approval process. The company recently filed a 510k request with the FDA for its bioflux technology (the 510k path is for medical devices rather than drugs, and as such doesn’t require a lot of regulatory deliberation), and has heard back from the FDA about a key part of the device already – it got the green light. Another arm of the FDA must look at other aspects of the device, and that portion of the review takes longer.
Still, the company is rightfully optimistic, so much so that it’s already lined up a company to manufacture the Bioflux device once the final approval and final specs are in. That company is Providence Enterprise, which has a long history in making drug delivery and diagnostic equipment, as well as plenty of experience making electronics. The Bioflux will be a blend of both capabilities.
- [By James E. Brumley]
When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.
General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.
Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.
The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.
Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It
- [By Bryan Murphy]
As much progress as the remote medical monitoring device market has made in recent years, we’ve still only scratched the surface. The surface has been scratched though. The Dexcom G5 mobile glucose monitor from DexCom, Inc. (NASDAQ:DXCM) is one impressive example. Arguably the first and best entry in the race, DexCom has sent a clear message that consumers and caregivers are ready for a functional device that takes care of itself.
At the other end of the spectrum is a recent round of products that are less clinical in nature, and more broad-usage friendly. Devices like the Apple Inc. (NASDAQ:AAPL) watch and the Fitbit Inc (NYSE:FIT) line of products are both capable of monitoring heart rates and activity. On the other, neither does it all that well… not like one would expect in a clinical setting. Fitbit has run into a headwind of legal and reputational trouble since it’s been verified that its trackers aren’t all that accurate; Apple avoided such trouble largely because few consumers ever viewed its watches as medical-grade hardware.
The gap between the Dexcom G5 and the Fitbit fitness trackers, however, is where real opportunity lies. See, the entries to date have proven there is a market for mobile medical devices , but have also proven they have to work as well as the equipment one might expect to find in a doctor’s office or in a hospital.
It’s this subtle nuance that puts a young company called Biotricity Inc. (OTCMKTS:BTCY) in the spotlight, as it has melded mobile monitoring and quality monitoring, and is now in the midst of making sure they’re marketable… not just to consumers, but to insurance companies (which tend to pay a lot more than the average consumer does). Fitbit missed the mark on both fronts.
Biotricity is working two different but similar pieces of technology. One is called bioflux, for use by caregivers in a clinical setting, and the other is biolife individuals outside of a clinical setting. Neither is o
Top 10 Value Stocks For 2018: CobalTech Mining Inc. (BNCIF)
- [By SEEKINGALPHA.COM]
The other junior cobalt miners include Brixton Metals Corporation (OTC:BXTMD) [TSXV:BBB], Canadian International Minerals [TSXV:CIN], Clean TeQ (OTCPK:CTEQF) [ASX:CLQ], Cobalt Power Group (TSXV:CPO), CobalTech Mining [TSXV:CSK] (OTCPK:BNCIF), Conico Ltd (ASX:CNJ), Corazon Mining Ltd [ASX:CZN], Dragon Energy (ASX:DLE), Highlands Pacific (OTC:HLPCF), Hinterland Metals Inc (TSXV:HMI) (OTC:HNLMF), and LiCo Energy Metals (TSXV:LIC) (OTCQB:WCTXF).
Top 10 Value Stocks For 2018: T2 Biosystems, Inc.(TTOO)
- [By William Romov]
Penny Stocks to Buy for December 2017, No. 5: T2 Biosystems Inc. (Nasdaq: TTOO)
Currently trading at $4.10 per share, T2 Biosystems Inc. (Nasdaq: TTOO) makes diagnostic products for biological in vitro research. It has the highest share price of the penny stocks on our list today.
- [By Lisa Levin]
Shares of T2 Biosystems Inc (NASDAQ: TTOO) were down 29 percent to $5.41. T2 Biosystems extended timeline for the completion of the T2Bacteria trial. BTIG downgraded the rating on T2 Biosystems from Buy to Sell, while lowering the price target from $12 to $4.
- [By Lisa Levin]
T2 Biosystems Inc (NASDAQ: TTOO) shares were also up, gaining 15 percent to $7.48 after the company disclosed a $40 million equity investment by partner Canon U.S.A.
Top 10 Value Stocks For 2018: Masco Corporation(MAS)
- [By Lisa Levin] Companies Reporting Before The Bell
United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
PACCAR Inc (NASDAQ: PCAR) is projected to
- [By ]
Masco (MAS) : “I like Masco. We have a housing shortage and that’s good for Masco.”
Over on Real Money, Cramer says the Netflix (NFLX) numbers show that cord-cutting is more than palpable. Get more of his insights with a free trial subscription to Real Money.
- [By WWW.THESTREET.COM]
Now, while Home Depot (HD) didn’t take off on these figures, Whirlpool (WHR) jumped more than four points. My take? Home Depot becomes a stock to put on your radar screen as we bounce around Dow 20,000. I am partial to Masco (MAS) , the kitchen and bath company, too, off these numbers.
- [By WWW.THESTREET.COM]
When companies break up, they can create enormous value, and nowhere is that more evident than with TopBuild (BLD) , the former services arm of Masco (MAS) that began trading as an independent company in July 2015. Since the spinoff, shares of TopBuild have rallied 50% and Cramer said the move is not yet over.
Top 10 Value Stocks For 2018: Seres Therapeutics, Inc.(MCRB)
- [By Lisa Levin] Gainers
Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
- [By Lisa Levin]
Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.
- [By Lisa Levin]
Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.
Top 10 Value Stocks For 2018: BioDelivery Sciences International Inc.(BDSI)
- [By Lisa Levin]
In trading on Tuesday, healthcare shares fell 0.48 percent. Meanwhile, top losers in the sector included MannKind Corporation (NASDAQ: MNKD), down 10 percent, and BioDelivery Sciences International, Inc. (NASDAQ: BDSI) down 10 percent.
- [By Jim Robertson]
On Friday, our Elite Opportunity Pronewsletter suggested small cap specialty pharmaceuticalstock BioDelivery Sciences International (NASDAQ: BDSI) as a bullish/long trade:
Top 10 Value Stocks For 2018: Taiwan Semiconductor Manufacturing Company Ltd.(TSM)
- [By Ashraf Eassa]
For many years, NVIDIA (NASDAQ:NVDA) has relied on Taiwan Semiconductor Manufacturing Company (NYSE:TSM) to manufacture the graphics chips it designs. Today, most of NVIDIA’s Pascal architecture-based graphics processors — from the GeForce GTX 1060, designed for mainstream PC gamers, all the way through its cutting edge Tesla P100 datacenter accelerators — are manufactured by TSMC.
- [By Garrett Baldwin]
Shares of Apple Inc. (Nasdaq: AAPL) may face additional pressure today after another surprise update from one of its biggest suppliers. Austria-based supplier AMS, a maker of optical sensors for the iPhone X, warned that sales for the second quarter will fall by roughly 50% from the first quarter. This comes not long after Taiwan Semiconductor Manufacturing Co. Ltd.(ADR) (NYSE: TSM) offered a lower-than-expected Q2 revenue forecast. Now, Wall Street analysts could soon follow with cuts to iPhone sales forecasts, especially after rival Samsung warned of a slowdown in display panel sales.
This morning, the European Central Bank announced it will maintain its record-low interest rates and accommodating monetary policy. At a time when the U.S. central bank is raising rates, the ECB failed to provide a timeline on when it will end its massive stimulus package, which features monthly bond purchases of $37 billion.
Four Stocks to Watch Today: DNKN, QSR, GM, FB
Hedge fund manager and notable short-seller Jim Chanos is lining up positions against two of the restaurant industry’s best-known firms. Shares of Dunkin Brands Group Inc.(Nasdaq: DNKN) and Restaurant Brands International Inc. (NYSE: QSR), which owns Burger King, were both sliding after Chanos said he was short the firms over sales concerns. The news comes the same morning that DNKN topped Wall Street profit estimates of $0.62 by $0.11. However, DNKN quarterly revenue fell short of expectations.
Facebook Inc. (Nasdaq: FB) stock doesn’t appear to be facing any significant fallout due to its ongoing data scandal. The social media giant shattered revenue expectations after the bell Wednesday. Shares popped 7% after the company reported a 50% year-over-year revenue surge. The firm reported 1.45 billion daily active users and 2.2 billion monthly users. This was the first earnings report since the Cambridge Analytica scandal that happened in March. Shares are rebounding, as the firm had lost billions in
- [By ]
Though it was hardly a secret going into April that iPhone X sales have come under pressure following a strong start, chip giant Taiwan Semiconductor’s (TSM) guidance and earnings call commentary suggests the slump is even more pronounced than many previously believed.
- [By Ashraf Eassa]
Contract chip manufacturing giantTaiwan Semiconductor Manufacturing Company(NYSE:TSM) announced that it expects its revenue for the entirety of 2018 to grow by “about 10%” — a downward revision from its previous forecast of between 10% and 15% revenue growth.
Top 10 Value Stocks For 2018: DRDGOLD Limited(DRD)
- [By Alex McGuire]
This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…
Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30)
DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24%
Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98%
Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56%
Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73%
Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89%
Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27%
Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25%
Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16%
Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75%
Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%
Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.
- [By Lisa Levin]
In trading on Wednesday, basic materials shares fell by 1.27 percent. Meanwhile, top losers in the sector included McEwen Mining Inc (NYSE: MUX), down 12 percent, and DRDGOLD Ltd. (ADR) (NYSE: DRD), down 7 percent.
- [By Lisa Levin]
Tuesday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Endeavour Silver Corp (NYSE: EXK) and DRDGOLD Ltd. (ADR) (NYSE: DRD).